vs
Side-by-side financial comparison of Primis Financial Corp. (FRST) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Primis Financial Corp. is the larger business by last-quarter revenue ($45.6M vs $39.6M, roughly 1.2× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 16.0%, a 19.9% gap on every dollar of revenue. Over the past eight quarters, Primis Financial Corp.'s revenue compounded faster (13.0% CAGR vs -15.0%).
Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
FRST vs SBC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $45.6M | $39.6M |
| Net Profit | $7.3M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | — | 32.5% |
| Net Margin | 16.0% | 35.9% |
| Revenue YoY | — | -10.9% |
| Net Profit YoY | 200.0% | 117.2% |
| EPS (diluted) | $0.30 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.6M | — | ||
| Q4 25 | $80.9M | $39.6M | ||
| Q3 25 | $41.0M | $43.4M | ||
| Q2 25 | $43.2M | $43.4M | ||
| Q1 25 | $58.7M | $47.3M | ||
| Q4 24 | $38.8M | $44.4M | ||
| Q3 24 | $37.3M | $53.1M | ||
| Q2 24 | $35.7M | $53.1M |
| Q1 26 | $7.3M | — | ||
| Q4 25 | $29.5M | $14.2M | ||
| Q3 25 | $6.8M | $12.8M | ||
| Q2 25 | $2.4M | $2.5M | ||
| Q1 25 | $22.6M | $21.5M | ||
| Q4 24 | $-26.2M | $6.5M | ||
| Q3 24 | $1.2M | $2.8M | ||
| Q2 24 | $3.4M | $18.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% |
| Q1 26 | — | — | ||
| Q4 25 | 44.8% | 32.5% | ||
| Q3 25 | 21.3% | 36.6% | ||
| Q2 25 | 6.9% | 33.6% | ||
| Q1 25 | 41.9% | 51.1% | ||
| Q4 24 | -123.0% | 10.6% | ||
| Q3 24 | -3.1% | 26.1% | ||
| Q2 24 | 7.8% | 51.4% |
| Q1 26 | 16.0% | — | ||
| Q4 25 | 36.5% | 35.9% | ||
| Q3 25 | 16.7% | 29.6% | ||
| Q2 25 | 5.6% | 5.7% | ||
| Q1 25 | 38.6% | 45.4% | ||
| Q4 24 | -100.3% | 14.7% | ||
| Q3 24 | 3.3% | 5.3% | ||
| Q2 24 | 9.6% | 34.8% |
| Q1 26 | $0.30 | — | ||
| Q4 25 | $1.19 | $0.15 | ||
| Q3 25 | $0.28 | $0.12 | ||
| Q2 25 | $0.10 | $0.02 | ||
| Q1 25 | $0.92 | $0.21 | ||
| Q4 24 | $-0.95 | $0.05 | ||
| Q3 24 | $0.05 | $0.03 | ||
| Q2 24 | $0.14 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.9M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $427.2M | $248.3M |
| Total Assets | $4.3B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $159.9M | — | ||
| Q4 25 | $143.6M | $164.1M | ||
| Q3 25 | $63.9M | $127.4M | ||
| Q2 25 | $94.1M | $152.7M | ||
| Q1 25 | $57.0M | $132.1M | ||
| Q4 24 | $64.5M | $125.0M | ||
| Q3 24 | $77.3M | $137.4M | ||
| Q2 24 | $66.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — |
| Q1 26 | $427.2M | — | ||
| Q4 25 | $422.9M | $248.3M | ||
| Q3 25 | $382.2M | $248.0M | ||
| Q2 25 | $376.4M | $244.6M | ||
| Q1 25 | $375.6M | $226.4M | ||
| Q4 24 | $351.8M | $195.1M | ||
| Q3 24 | $381.0M | $205.0M | ||
| Q2 24 | $376.0M | $8.8M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.0B | $380.4M | ||
| Q3 25 | $4.0B | $321.4M | ||
| Q2 25 | $3.9B | $315.3M | ||
| Q1 25 | $3.7B | $284.6M | ||
| Q4 24 | $3.7B | $266.1M | ||
| Q3 24 | $4.0B | $296.5M | ||
| Q2 24 | $4.0B | $19.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.8M | $52.0M | ||
| Q3 25 | $-11.4M | $-20.9M | ||
| Q2 25 | $-41.0M | $-8.3M | ||
| Q1 25 | $34.4M | $1.9M | ||
| Q4 24 | $19.5M | $-7.3M | ||
| Q3 24 | $6.1M | $5.0M | ||
| Q2 24 | $52.3M | $19.2M |
| Q1 26 | — | — | ||
| Q4 25 | $9.0M | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | $18.3M | $-7.9M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $18.3M |
| Q1 26 | — | — | ||
| Q4 25 | 11.2% | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | 47.3% | -17.8% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 34.5% |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | 3.1% | 1.3% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.36× | 3.66× | ||
| Q3 25 | -1.67× | -1.63× | ||
| Q2 25 | -16.82× | -3.39× | ||
| Q1 25 | 1.52× | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 4.93× | 1.77× | ||
| Q2 24 | 15.21× | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
